Equine protozoal myeloencephalitis (EPM) is a common infectious neurologic disease of horses in the Americas. Because the parasite can lodge anywhere in the central nervous system, almost any neurologic sign is possible, which makes the clues (asymmetry, focal muscle atrophy, no pain or fever) and the correct use of antibody testing the main exam content.
Key facts
Equine protozoal myeloencephalitis (Sarcocystis neurona and Neospora hughesi) at a glance- Species and system: horses; central nervous system, mostly the spinal cord.
- Cause (MSD): most cases are Sarcocystis neurona; sporadic cases with Neospora hughesi.
- Life cycle: opossum is the definitive host; horses ingest sporocysts in feed or water and are dead-end hosts.
- Classic signs: asymmetric or symmetric ataxia and weakness, focal muscle atrophy; not typically painful or febrile.
- Diagnosis: exclusion of other causes plus intrathecal antibody (serum:CSF ratio); postmortem confirmation shows protozoa.
- Treatment (FDA-approved): ponazuril, diclazuril or sulfadiazine with pyrimethamine.
- Zoonotic or reportable: no. No proven vaccine.
What's inside
12 sections in the full guide- Key facts
- How the NAVLE tests this
- Cause and pathophysiology
- Clinical signs
- Diagnosis
- Differential diagnoses
- Treatment and management
- Prevention, control and public health
- Prognosis
- Quick review
- Test yourself
- References
The full guide also has 4 tables, 1 figure, 3 self-test questions and 5 references, available to NAVLE members.
Read the full study guide
The full guide is part of every NAVLE plan, with diagnosis and treatment tables, figures, a quick review and self-test questions. Start a free trial to try the question bank, or log in if you are already a member.